284 related articles for article (PubMed ID: 16905642)
1. Serum cholesterol levels and the risk of Parkinson's disease.
de Lau LM; Koudstaal PJ; Hofman A; Breteler MM
Am J Epidemiol; 2006 Nov; 164(10):998-1002. PubMed ID: 16905642
[TBL] [Abstract][Full Text] [Related]
2. Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease.
Sohmiya M; Tanaka M; Tak NW; Yanagisawa M; Tanino Y; Suzuki Y; Okamoto K; Yamamoto Y
J Neurol Sci; 2004 Aug; 223(2):161-6. PubMed ID: 15337618
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of coenzyme Q10 in patients with Parkinson's disease.
Jiménez-Jiménez FJ; Molina JA; de Bustos F; García-Redondo A; Gómez-Escalonilla C; Martínez-Salio A; Berbel A; Camacho A; Zurdo M; Barcenilla B; Enríquez de Salamanca R; Arenas J
J Neural Transm (Vienna); 2000; 107(2):177-81. PubMed ID: 10847558
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of coffee consumption and risk of Parkinson's disease.
Sääksjärvi K; Knekt P; Rissanen H; Laaksonen MA; Reunanen A; Männistö S
Eur J Clin Nutr; 2008 Jul; 62(7):908-15. PubMed ID: 17522612
[TBL] [Abstract][Full Text] [Related]
5. Type 2 diabetes and the risk of Parkinson's disease.
Hu G; Jousilahti P; Bidel S; Antikainen R; Tuomilehto J
Diabetes Care; 2007 Apr; 30(4):842-7. PubMed ID: 17251276
[TBL] [Abstract][Full Text] [Related]
6. Total cholesterol and the risk of Parkinson disease.
Hu G; Antikainen R; Jousilahti P; Kivipelto M; Tuomilehto J
Neurology; 2008 May; 70(21):1972-9. PubMed ID: 18401018
[TBL] [Abstract][Full Text] [Related]
7. [Serum pro-oxidant and antioxidant factors and risk of Parkinson's disease: population study].
Molina-Arjona JA; de Bustos F; Benito-León J; Jiménez-Jiménez FJ; Rodríguez J; Trincado R; Porta-Etessan J; Vega S; Bermejo F
Rev Neurol; 1999 Jul 1-15; 29(1):12-5. PubMed ID: 10528302
[TBL] [Abstract][Full Text] [Related]
8. Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease.
de Lau LM; Stricker BH; Breteler MM
Mov Disord; 2007 Oct; 22(13):1985. PubMed ID: 17557354
[No Abstract] [Full Text] [Related]
9. Body mass index and risk of Parkinson's disease: a prospective cohort study.
Logroscino G; Sesso HD; Paffenbarger RS; Lee IM
Am J Epidemiol; 2007 Nov; 166(10):1186-90. PubMed ID: 17709328
[TBL] [Abstract][Full Text] [Related]
10. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease.
Shults CW; Flint Beal M; Song D; Fontaine D
Exp Neurol; 2004 Aug; 188(2):491-4. PubMed ID: 15246848
[TBL] [Abstract][Full Text] [Related]
11. Number of children and risk of Parkinson's disease.
Frigerio R; Breteler MM; de Lau LM; Sanft KR; Bower JH; Ahlskog JE; Grossardt BR; ; Maraganore DM; Rocca WA
Mov Disord; 2007 Apr; 22(5):632-9. PubMed ID: 17265462
[TBL] [Abstract][Full Text] [Related]
12. Coenzyme Q 10 and cardiovascular risk factors in idiopathic sudden sensorineural hearing loss patients.
Cadoni G; Scipione S; Agostino S; Addolorato G; Cianfrone F; Leggio L; Paludetti G; Lippa S
Otol Neurotol; 2007 Oct; 28(7):878-83. PubMed ID: 17558340
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.
Bornebroek M; de Lau LM; Haag MD; Koudstaal PJ; Hofman A; Stricker BH; Breteler MM
Neuroepidemiology; 2007; 28(4):193-6. PubMed ID: 17851257
[TBL] [Abstract][Full Text] [Related]
14. Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression.
Ikeda K; Nakamura Y; Kiyozuka T; Aoyagi J; Hirayama T; Nagata R; Ito H; Iwamoto K; Murata K; Yoshii Y; Kawabe K; Iwasaki Y
Neurodegener Dis; 2011; 8(4):252-8. PubMed ID: 21282940
[TBL] [Abstract][Full Text] [Related]
15. Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson's disease.
Isobe C; Murata T; Sato C; Terayama Y
J Clin Neurosci; 2007 Apr; 14(4):340-3. PubMed ID: 16647853
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
17. [Incidence of idiopathic and secondary Parkinson disease in Navarre. Population-based case registry].
Viñes JJ; Larumbe R; Gaminde I; Artázcoz MT
Neurologia; 1999 Jan; 14(1):16-22. PubMed ID: 10079687
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of lipid peroxides in patients with Parkinson's disease.
Sanyal J; Bandyopadhyay SK; Banerjee TK; Mukherjee SC; Chakraborty DP; Ray BC; Rao VR
Eur Rev Med Pharmacol Sci; 2009; 13(2):129-32. PubMed ID: 19499848
[TBL] [Abstract][Full Text] [Related]
19. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
[TBL] [Abstract][Full Text] [Related]
20. Role of serum cholesterol in Parkinson's disease: a meta-analysis of evidence.
Gudala K; Bansal D; Muthyala H
J Parkinsons Dis; 2013 Jan; 3(3):363-70. PubMed ID: 23948990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
